1. Home
  2. TURB vs CTXR Comparison

TURB vs CTXR Comparison

Compare TURB & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turbo Energy S.A.

TURB

Turbo Energy S.A.

HOLD

Current Price

$1.51

Market Cap

16.5M

Sector

N/A

ML Signal

HOLD

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

HOLD

Current Price

$0.57

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TURB
CTXR
Founded
2013
2007
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5M
18.9M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
TURB
CTXR
Price
$1.51
$0.57
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
403.1K
243.2K
Earning Date
04-17-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.38
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$147.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.48
52 Week High
$20.44
$2.24

Technical Indicators

Market Signals
Indicator
TURB
CTXR
Relative Strength Index (RSI) 50.24 48.75
Support Level $1.44 $0.55
Resistance Level $2.02 $0.60
Average True Range (ATR) 0.12 0.04
MACD 0.01 0.01
Stochastic Oscillator 60.61 53.66

Price Performance

Historical Comparison
TURB
CTXR

About TURB Turbo Energy S.A.

Turbo Energy SA is an integrator of AI-driven energy storage and intelligent energy management solutions focused on transforming how energy is generated, stored, optimized, and consumed across residential, commercial, industrial, and utility-scale applications. It operates at the intersection of renewable energy infrastructure, energy storage, and software-driven optimization, combining battery systems, solar integration, and proprietary Artificial Intelligence (AI) technologies into unified intelligent energy platforms. Its solutions are designed to help customers reduce energy costs, improve operational resilience, increase energy independence, and optimize energy performance in increasingly decentralized and volatile energy markets. It generates the majority of its revenue from Spain.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: